Literature DB >> 18387001

Translational regulation of lipoprotein lipase in adipocytes: depletion of cellular protein kinase Calpha activates binding of the C subunit of protein kinase A to the 3'-untranslated region of the lipoprotein lipase mRNA.

Resat Unal1, Irina Pokrovskaya, Preeti Tripathi, Brett P Monia, Philip A Kern, Gouri Ranganathan.   

Abstract

Adipose LPL (lipoprotein lipase) plays an important role in regulating plasma triacylglycerols and lipid metabolism. We have previously demonstrated that PKCalpha (protein kinase Calpha) depletion inhibits LPL translation in 3T3-F442A adipocytes. Using in vitro translation experiments, the minimum essential region on the 3'UTR (3'-untranslated region) of LPL mRNA required for the inhibition of translation was identified as the proximal 39 nt. These results were confirmed by RNase protection analysis using cytoplasmic proteins isolated from the adipocytes treated with PKCalpha antisense oligomers and the LPL 3'UTR transcript (LPL 3'UTR nt: 1512-1640). The protein components involved in this RNA-binding interaction from PKCalpha depletion were passed through an affinity column containing a sequence of the LPL 3'UTR and, after Western blotting, the RNA-binding proteins were identified as the catalytic and the regulatory subunits of PKA (protein kinase A), Calpha and RIIbeta, and AKAP (A-kinase-anchoring protein) 121. This RNA inhibitory complex consisted of the same RNA-binding proteins that have been identified previously as mediators of LPL translational inhibition by PKA activation, suggesting that PKCalpha depletion inhibits LPL translation through PKA activation. In additional experiments, PKC depletion by prolonged PMA treatment or PKCalpha antisense oligomers resulted in an increase in PKA activity in 3T3-F442A adipocytes, comparable with PKA activation with adrenaline (epinephrine) treatment. These results demonstrate that LPL translational inhibition occurs through an RNA-binding complex involving PKA subunits and AKAP121, and this complex can be activated either through traditional PKA activation methods or through the depletion of PKCalpha.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18387001      PMCID: PMC2755514          DOI: 10.1042/BJ20071559

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  29 in total

1.  The translational regulation of lipoprotein lipase in diabetic rats involves the 3'-untranslated region of the lipoprotein lipase mRNA.

Authors:  G Ranganathan; C Li; P A Kern
Journal:  J Biol Chem       Date:  2000-12-29       Impact factor: 5.157

Review 2.  Antisense oligonucleotides as inhibitors of signal transduction: development from research tools to therapeutic agents.

Authors:  N M Dean; R McKay; L Miraglia; T Geiger; M Müller; D Fabbro; C F Bennett
Journal:  Biochem Soc Trans       Date:  1996-08       Impact factor: 5.407

Review 3.  Lipoprotein lipase: genetics, lipid uptake, and regulation.

Authors:  Martin Merkel; Robert H Eckel; Ira J Goldberg
Journal:  J Lipid Res       Date:  2002-12       Impact factor: 5.922

4.  Tissue-specific regulation of lipoprotein lipase by isoproterenol in normal-weight humans.

Authors:  R H Eckel; D R Jensen; I R Schlaepfer; T J Yost
Journal:  Am J Physiol       Date:  1996-11

5.  Regulation of lipoprotein lipase translation by epinephrine in 3T3-L1 cells. Importance of the 3' untranslated region.

Authors:  A Yukht; R C Davis; J M Ong; G Ranganathan; P A Kern
Journal:  J Clin Invest       Date:  1995-11       Impact factor: 14.808

6.  Tissue-specific expression of human lipoprotein lipase. Effect of the 3'-untranslated region on translation.

Authors:  G Ranganathan; J M Ong; A Yukht; M Saghizadeh; R B Simsolo; A Pauer; P A Kern
Journal:  J Biol Chem       Date:  1995-03-31       Impact factor: 5.157

7.  Regulation of lipoprotein lipase by protein kinase C alpha in 3T3-F442A adipocytes.

Authors:  Gouri Ranganathan; Wei Song; Nicholas Dean; Brett Monia; Steven W Barger; Philip A Kern
Journal:  J Biol Chem       Date:  2002-07-30       Impact factor: 5.157

Review 8.  Lipoprotein lipase: the regulation of tissue specific expression and its role in lipid and energy metabolism.

Authors:  Karina Preiss-Landl; Robert Zimmermann; Günter Hämmerle; Rudolf Zechner
Journal:  Curr Opin Lipidol       Date:  2002-10       Impact factor: 4.776

9.  ERKs are the point of divergence of PKA and PKC activation by PTHrP in human skin fibroblasts.

Authors:  V Fortino; C Torricelli; C Gardi; G Valacchi; S Rossi Paccani; E Maioli
Journal:  Cell Mol Life Sci       Date:  2002-12       Impact factor: 9.261

10.  The translational regulation of lipoprotein lipase by epinephrine involves an RNA binding complex including the catalytic subunit of protein kinase A.

Authors:  Gouri Ranganathan; Dan Phan; Irina D Pokrovskaya; Joan E McEwen; Chunling Li; Philip A Kern
Journal:  J Biol Chem       Date:  2002-09-05       Impact factor: 5.157

View more
  4 in total

Review 1.  Role of protein kinase A in regulating mitochondrial function and neuronal development: implications to neurodegenerative diseases.

Authors:  Ruben K Dagda; Tania Das Banerjee
Journal:  Rev Neurosci       Date:  2015       Impact factor: 4.353

2.  Matrix metalloproteinase-9 is increased in obese subjects and decreases in response to pioglitazone.

Authors:  Resat Unal; Aiwei Yao-Borengasser; Vijayalakshmi Varma; Neda Rasouli; Craig Labbate; Philip A Kern; Gouri Ranganathan
Journal:  J Clin Endocrinol Metab       Date:  2010-04-14       Impact factor: 5.958

3.  Adiponectin translation is increased by the PPARgamma agonists pioglitazone and omega-3 fatty acids.

Authors:  Anannya Banga; Resat Unal; Preeti Tripathi; Irina Pokrovskaya; Randall J Owens; Philip A Kern; Gouri Ranganathan
Journal:  Am J Physiol Endocrinol Metab       Date:  2008-12-16       Impact factor: 4.310

Review 4.  Regulation of the steroidogenic acute regulatory protein gene expression: present and future perspectives.

Authors:  Pulak R Manna; Matthew T Dyson; Douglas M Stocco
Journal:  Mol Hum Reprod       Date:  2009-03-25       Impact factor: 4.025

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.